| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.40▼ | 1.40▼ | 1.41▼ | 1.40▼ | 1.42▼ |
| MA10 | 1.41▼ | 1.42▼ | 1.43▼ | 1.42▼ | 1.22▲ |
| MA20 | 1.43▼ | 1.42▼ | 1.41▼ | 1.44▼ | 1.12▲ |
| MA50 | 1.42▼ | 1.42▼ | 1.43▼ | 1.21▲ | 1.28▲ |
| MA100 | 1.42▼ | 1.46▼ | 1.44▼ | 1.11▲ | 1.61▼ |
| MA200 | 1.46▼ | 1.43▼ | 1.30▲ | 1.22▲ | 2.02▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | -0.006▼ | -0.003▼ | -0.023▼ | 0.064▲ |
| RSI | 33.288▼ | 39.081▼ | 40.819▼ | 52.215▲ | 56.545▲ |
| STOCH | 9.722▼ | 8.449▼ | 30.010 | 22.372 | 47.213 |
| WILL %R | -92.308▼ | -93.750▼ | -93.750▼ | -87.719▼ | -55.495 |
| CCI | -155.175▼ | -132.780▼ | -83.951 | -76.304 | 85.757 |
|
Thursday, April 30, 2026 02:18 PM
Ongoing Phase 1b human challenge study with oral, direct-acting protease inhibitor is designed to demonstrate proof-of-concept as a preventive and a treatmentFully enrolled first cohort is assessing ...
|
|
Monday, March 09, 2026 05:00 AM
BOTHELL, Wash., March 09, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces the first subjects have been dosed in a Phase 1b norovirus challenge ...
|
|
Monday, March 09, 2026 05:00 AM
BOTHELL, Wash., March 09, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces the first subjects have been dosed in a Phase 1b norovirus challenge ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/26 | 1.45 | 1.45 | 1.38 | 1.38 | 144,386 |
| 30/04/26 | 1.40 | 1.4798 | 1.395 | 1.43 | 135,913 |
| 29/04/26 | 1.38 | 1.40 | 1.37 | 1.39 | 117,195 |
| 28/04/26 | 1.3506 | 1.42 | 1.3506 | 1.39 | 72,591 |
| 27/04/26 | 1.45 | 1.45 | 1.40 | 1.40 | 109,180 |
| 24/04/26 | 1.41 | 1.45 | 1.375 | 1.43 | 132,839 |
| 23/04/26 | 1.46 | 1.4799 | 1.39 | 1.41 | 191,607 |
| 22/04/26 | 1.42 | 1.49 | 1.42 | 1.47 | 80,517 |
| 21/04/26 | 1.49 | 1.5043 | 1.41 | 1.43 | 148,489 |
| 20/04/26 | 1.51 | 1.53 | 1.48 | 1.51 | 178,202 |
|
|
||||
|
|
||||
|
|